Reaching Beyond the Limits of Enzyme Replacement Therapies with Gene Therapies

Geoff MacKay, president and CEO of Avrobio, discusses cystinosis, the company’s gene therapy platform, and how it's leveraging its technology to develop therapies across a range of rare diseases.